Edwin Chang

Affiliations: 
Radiology Stanford University School of Medicine, Palo Alto, CA, United States 
Google:
"Edwin Chang"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nguyen H, Schubert KE, Pohling C, et al. (2024) Impact of glioma peritumoral edema, tumor size, and tumor location on alternating electric fields (AEF) therapy in realistic 3D rat glioma models: a computational study. Physics in Medicine and Biology
Nguyen H, Schubert KE, Chang E, et al. (2023) Electric field distributions in realistic 3D rat head models during alternating electric field (AEF) therapy: a computational study. Physics in Medicine and Biology
Pohling C, Nguyen H, Chang E, et al. (2022) Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy. Bioelectrochemistry (Amsterdam, Netherlands). 149: 108287
Arami H, Kananian S, Khalifehzadeh L, et al. (2022) Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostars. Nature Nanotechnology
Wu W, Klockow JL, Zhang M, et al. (2021) Glioblastoma Multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacological Research. 105780
Aguilar AA, Ho MC, Chang E, et al. (2021) Permeabilizing Cell Membranes with Electric Fields. Cancers. 13
Patel C, Beinat C, Xie Y, et al. (2021) BIMG-16. TRACKING TTFIELDS-INDUCED ALTERATIONS IN GLIOBLASTOMA METABOLISM WITH [18F]DASA-23, A NON-INVASIVE PROBE OF PYRUVATE KINASE M2 (PKM2) Neuro-Oncology Advances. 3: i4-i4
Patel CB, Beinat C, Xie Y, et al. (2020) Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression. Neoplasia (New York, N.Y.). 23: 58-67
Chang E, Patel C, Young C, et al. (2020) CSIG-14. COMBINING THE GLIOBLASTOMA CELL MEMBRANE-PERMEABILIZING EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) WITH WITHAFERIN A (AND OTHER) CHEMOTHERAPY Neuro-Oncology. 22: ii30-ii30
Patel CB, Beinat C, Xie Y, et al. (2019) Abstract 5271: Molecular imaging of pyruvate kinase M2 (PKM2) with [18F]DASA-23 detects temozolomide- and tumor treating fields (TTFields)-induced changes in glycolysis in glioblastoma Cancer Research. 79: 5271-5271
See more...